首页 > 最新文献

Chinese Neurosurgical Journal最新文献

英文 中文
Simultaneous biportal endoscopic management of pineal region tumors in patients with obstructive hydrocephalus: technical notes. 同时双门静脉内镜治疗阻塞性脑积水患者的松果体区肿瘤:技术注意事项。
Q2 Medicine Pub Date : 2023-01-10 DOI: 10.1186/s41016-022-00313-0
Sultan Al-Saiari, Khalid Al Orabi, Mohammad Ghazi Abdoh, Abdulaziz A Basurrah, Sultan Faez Albalawi, Ahmed A Farag

Background: The goal of this study is to show the feasibility and benefits of using the simultaneous biportal endoscopic procedure to treat pineal tumors in patients with obstructive hydrocephalus.

Methods: We retrospectively reviewed three patients with pineal tumors and acute obstructive hydrocephalus who were treated in one session with a frameless stereotactic guided simultaneous biportal endoscopic third ventriculostomy and endoscopic tumor biopsy performed through two separate ports using one rigid ventriculoscope.

Results: In the three patients, ventriculostomy and endoscopic biopsies were conducted. There was no death or morbidity throughout the 45-min procedure. All of the patients' histological findings were confirmed. Germinoma was diagnosed in two patients who recieved postoperative radiotherapy, and the third patient diagnosed with a pineocytoma. Magnetic resonance imaging with flow-sensitive sequences was used to confirm ventriculostomy patency in all patients 6 months after the surgery.

Conclusion: Biportal endoscopic approach enables better visual control of both procedures. Furthermore, it allows the surgeon to safely pass the ventriculoscope via the foramen of monro, even if it is narrow. Moreover, during endoscopic tumor biopsy and third ventriculostomy, the intracranial pressure can be smoothly managed using the outlet tubes accessible. This treatment may be an alternative to traditional uniportal endoscopic operations in certain patients.

背景:本研究的目的是显示同时双门静脉内镜手术治疗阻塞性脑积水患者松果体肿瘤的可行性和益处。方法:我们回顾性分析了3例松果体肿瘤合并急性阻塞性脑积水的患者,他们在一个刚性脑室镜下通过两个单独的口进行无框架立体定向引导的双门静脉内镜第三脑室造口术和内镜肿瘤活检。结果:3例患者均行脑室造口术和内镜活检。在45分钟的手术过程中没有死亡或发病。所有患者的组织学检查结果均得到证实。两名接受术后放疗的患者被诊断为生殖细胞瘤,第三名患者被诊断为松果体细胞瘤。所有患者术后6个月均采用流敏感序列磁共振成像证实脑室造口通畅。结论:双门静脉内镜入路对两种手术均有较好的视觉控制。此外,它允许外科医生安全地通过脑室镜通过门孔,即使它很窄。此外,在内镜下肿瘤活检和第三脑室造口术中,可利用出口管顺利控制颅内压。在某些患者中,这种治疗可能是传统单门静脉内窥镜手术的替代方法。
{"title":"Simultaneous biportal endoscopic management of pineal region tumors in patients with obstructive hydrocephalus: technical notes.","authors":"Sultan Al-Saiari,&nbsp;Khalid Al Orabi,&nbsp;Mohammad Ghazi Abdoh,&nbsp;Abdulaziz A Basurrah,&nbsp;Sultan Faez Albalawi,&nbsp;Ahmed A Farag","doi":"10.1186/s41016-022-00313-0","DOIUrl":"https://doi.org/10.1186/s41016-022-00313-0","url":null,"abstract":"<p><strong>Background: </strong>The goal of this study is to show the feasibility and benefits of using the simultaneous biportal endoscopic procedure to treat pineal tumors in patients with obstructive hydrocephalus.</p><p><strong>Methods: </strong>We retrospectively reviewed three patients with pineal tumors and acute obstructive hydrocephalus who were treated in one session with a frameless stereotactic guided simultaneous biportal endoscopic third ventriculostomy and endoscopic tumor biopsy performed through two separate ports using one rigid ventriculoscope.</p><p><strong>Results: </strong>In the three patients, ventriculostomy and endoscopic biopsies were conducted. There was no death or morbidity throughout the 45-min procedure. All of the patients' histological findings were confirmed. Germinoma was diagnosed in two patients who recieved postoperative radiotherapy, and the third patient diagnosed with a pineocytoma. Magnetic resonance imaging with flow-sensitive sequences was used to confirm ventriculostomy patency in all patients 6 months after the surgery.</p><p><strong>Conclusion: </strong>Biportal endoscopic approach enables better visual control of both procedures. Furthermore, it allows the surgeon to safely pass the ventriculoscope via the foramen of monro, even if it is narrow. Moreover, during endoscopic tumor biopsy and third ventriculostomy, the intracranial pressure can be smoothly managed using the outlet tubes accessible. This treatment may be an alternative to traditional uniportal endoscopic operations in certain patients.</p>","PeriodicalId":36700,"journal":{"name":"Chinese Neurosurgical Journal","volume":"9 1","pages":"1"},"PeriodicalIF":0.0,"publicationDate":"2023-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830701/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10869802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Monitored anesthesia care and asleep-awake-asleep techniques combined with multiple monitoring for resection of gliomas in eloquent brain areas: a retrospective analysis of 225 patients. 监测麻醉护理和睡眠-觉醒-睡眠技术结合多重监测对225例脑区胶质瘤切除术的回顾性分析。
Q2 Medicine Pub Date : 2022-12-30 DOI: 10.1186/s41016-022-00311-2
San-Zhong Li, Ning Su, Shuang Wu, Xiao-Wei Fei, Xin He, Jiu-Xiang Zhang, Xiao-Hui Wang, Hao-Peng Zhang, Xiao-Guang Bai, Guang Cheng, Zhou Fei

Background: Awake craniotomy (AC) has become gold standard in surgical resection of gliomas located in eloquent areas. The conscious sedation techniques in AC include both monitored anesthesia care (MAC) and asleep-awake-asleep (AAA). The choice of optimal anesthetic method depends on the preferences of the surgical team (mainly anesthesiologist and neurosurgeon). The aim of this study was to compare the difference in physiological and blood gas data, dosage of different drugs, the probability of switching to endotracheal intubation, and extent of tumor resection and dysfunction after operation between AAA and MAC anesthetic management for resection of gliomas in eloquent brain areas.

Methods: Two-hundred and twenty-five patients with super-tentorial tumor located in eloquent areas underwent AC from 2009 to 2021 in Xijing Hospital. Forty-one patients underwent AAA technique, and the rest one-hundred eighty-four patients underwent MAC technique. Anesthetic management, dosage of different drugs, intraoperative complications, postoperative outcomes, adverse events, extent of resection and motor, and sensory and language dysfunction after operation were compared between MAC and AAA.

Result: There was no significant difference in gender, KPS score, MMSE score, glioma grade, type, and growth site between the patients in the two groups, except the older age of patients in MAC group than that in AAA group. During the whole process of operation, there were greater pulse pressure difference (P = 0.046), shorter operation time (P = 0.039), less dosage of remifentanil (P = 0.000), more dosage of dexmedetomidine (P = 0.013), more use of antiemetics (81%, P = 0.0067), lower use of vasoactive agent (45.1%, P = 0.010), and lower probability of conversion to general anesthesia (GA, P = 0.027) in MAC group than that in AAA group. Blood gas analysis showed that PetCO2 (P = 0.000), Glu concentration (P = 0.000), and PaCO2 (P = 0.000) were higher, but SPO2 (P = 0.002) and PaO2 (P = 0.000) were lower in MAC group than that in AAA group. In the postoperative recovery stage, compared with that of AAA group, the probability of dysfunction in MAC group at 1, 3, 5, and 7 days after operation was lower, which were 27.8% vs 53.6% (P = 0.003), 31% vs 68.3% (P = 0.000), 28.8% vs 63.4% (P = 0.000), and 25.6% vs 58.5% (P = 0.000), respectively.

Conclusion: Compared with AAA, it seems that MAC has more advantages in the management for resection of gliomas in eloquent brain areas, and MAC combined with multiple monitoring such as cerebral cortical mapping, neuronavigation, and ultrasonic detection is worthy of popularization for the resection of gliomas in eloquent brain areas.

背景:清醒开颅术(AC)已成为手术切除位于雄辩区胶质瘤的金标准。有意识镇静技术包括麻醉监护(MAC)和睡眠-觉醒-睡眠(AAA)。最佳麻醉方法的选择取决于手术团队(主要是麻醉师和神经外科医生)的偏好。本研究的目的是比较AAA麻醉与MAC麻醉在脑功能区胶质瘤切除术中的生理血气数据、不同药物用量、转气管插管概率、肿瘤切除程度及术后功能障碍的差异。方法:2009年至2021年,西京医院250例位于交界区的超幕肿瘤患者行体外循环治疗。41例采用AAA技术,其余184例采用MAC技术。比较MAC组和AAA组患者的麻醉处理、不同药物剂量、术中并发症、术后结局、不良事件、术后切除程度、运动、感觉和语言功能障碍。结果:两组患者在性别、KPS评分、MMSE评分、胶质瘤分级、类型、生长部位等方面均无显著差异,MAC组患者年龄明显大于AAA组。在整个手术过程中,MAC组患者脉压差较大(P = 0.046),手术时间较短(P = 0.039),瑞芬太尼用量较少(P = 0.000),右美托咪定用量较多(P = 0.013),止吐药用量较多(81%,P = 0.0067),血管活性药物用量较少(45.1%,P = 0.010),转全身麻醉概率较AAA组低(GA, P = 0.027)。血气分析显示,MAC组PetCO2 (P = 0.000)、Glu浓度(P = 0.000)、PaCO2 (P = 0.000)升高,SPO2 (P = 0.002)、PaO2 (P = 0.000)低于AAA组。术后恢复期,与AAA组相比,MAC组术后1、3、5、7 d功能障碍发生率分别为27.8%比53.6% (P = 0.003)、31%比68.3% (P = 0.000)、28.8%比63.4% (P = 0.000)、25.6%比58.5% (P = 0.000)。结论:与AAA相比,MAC在雄辩区胶质瘤切除术的治疗中似乎更有优势,MAC联合大脑皮质作图、神经导航、超声检测等多种监测在雄辩区胶质瘤切除术中值得推广。
{"title":"Monitored anesthesia care and asleep-awake-asleep techniques combined with multiple monitoring for resection of gliomas in eloquent brain areas: a retrospective analysis of 225 patients.","authors":"San-Zhong Li,&nbsp;Ning Su,&nbsp;Shuang Wu,&nbsp;Xiao-Wei Fei,&nbsp;Xin He,&nbsp;Jiu-Xiang Zhang,&nbsp;Xiao-Hui Wang,&nbsp;Hao-Peng Zhang,&nbsp;Xiao-Guang Bai,&nbsp;Guang Cheng,&nbsp;Zhou Fei","doi":"10.1186/s41016-022-00311-2","DOIUrl":"https://doi.org/10.1186/s41016-022-00311-2","url":null,"abstract":"<p><strong>Background: </strong>Awake craniotomy (AC) has become gold standard in surgical resection of gliomas located in eloquent areas. The conscious sedation techniques in AC include both monitored anesthesia care (MAC) and asleep-awake-asleep (AAA). The choice of optimal anesthetic method depends on the preferences of the surgical team (mainly anesthesiologist and neurosurgeon). The aim of this study was to compare the difference in physiological and blood gas data, dosage of different drugs, the probability of switching to endotracheal intubation, and extent of tumor resection and dysfunction after operation between AAA and MAC anesthetic management for resection of gliomas in eloquent brain areas.</p><p><strong>Methods: </strong>Two-hundred and twenty-five patients with super-tentorial tumor located in eloquent areas underwent AC from 2009 to 2021 in Xijing Hospital. Forty-one patients underwent AAA technique, and the rest one-hundred eighty-four patients underwent MAC technique. Anesthetic management, dosage of different drugs, intraoperative complications, postoperative outcomes, adverse events, extent of resection and motor, and sensory and language dysfunction after operation were compared between MAC and AAA.</p><p><strong>Result: </strong>There was no significant difference in gender, KPS score, MMSE score, glioma grade, type, and growth site between the patients in the two groups, except the older age of patients in MAC group than that in AAA group. During the whole process of operation, there were greater pulse pressure difference (P = 0.046), shorter operation time (P = 0.039), less dosage of remifentanil (P = 0.000), more dosage of dexmedetomidine (P = 0.013), more use of antiemetics (81%, P = 0.0067), lower use of vasoactive agent (45.1%, P = 0.010), and lower probability of conversion to general anesthesia (GA, P = 0.027) in MAC group than that in AAA group. Blood gas analysis showed that PetCO2 (P = 0.000), Glu concentration (P = 0.000), and PaCO2 (P = 0.000) were higher, but SPO2 (P = 0.002) and PaO2 (P = 0.000) were lower in MAC group than that in AAA group. In the postoperative recovery stage, compared with that of AAA group, the probability of dysfunction in MAC group at 1, 3, 5, and 7 days after operation was lower, which were 27.8% vs 53.6% (P = 0.003), 31% vs 68.3% (P = 0.000), 28.8% vs 63.4% (P = 0.000), and 25.6% vs 58.5% (P = 0.000), respectively.</p><p><strong>Conclusion: </strong>Compared with AAA, it seems that MAC has more advantages in the management for resection of gliomas in eloquent brain areas, and MAC combined with multiple monitoring such as cerebral cortical mapping, neuronavigation, and ultrasonic detection is worthy of popularization for the resection of gliomas in eloquent brain areas.</p>","PeriodicalId":36700,"journal":{"name":"Chinese Neurosurgical Journal","volume":"8 1","pages":"45"},"PeriodicalIF":0.0,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801549/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10517228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Clinical characteristics and survival of glioblastoma complicated with non-central nervous system tumors. 胶质母细胞瘤合并非中枢神经系统肿瘤的临床特点及生存率。
Q2 Medicine Pub Date : 2022-12-27 DOI: 10.1186/s41016-022-00312-1
Chen Wang, Di Wang, Changqing Pan, Jiazheng Zhang, Cheng Cheng, You Zhai, Mingchen Yu, Zhiliang Wang, Guanzhang Li, Wei Zhang

Background: Diagnosis and treatment of patients with glioblastoma (GBM) who are also diagnosed with primary non-central nervous system (CNS) tumors remain a challenge, yet little is known about the clinical characteristics and prognosis of these patients. The data presented here compared the clinical and pathological features between glioblastoma patients with or without primary non-CNS tumors, trying to further explore this complex situation.

Methods: Statistical analysis was based on the clinical and pathological data of 45 patients who were diagnosed with isocitrate dehydrogenase (IDH) wild-type glioblastoma accompanied by non-CNS tumors between January 2019 and February 2022 in Beijing Tiantan Hospital. Univariate COX proportional hazard regression model was used to determine risk factors for overall survival.

Results: It turned out to be no significant difference in the overall survival (OS) of the 45 patients with IDH-wild-type GBM plus non-CNS tumors, compared with the 112 patients who were only diagnosed with IDH-wild-type GBM. However, there was a significant difference in OS of GBM patients with benign tumors compared to those with malignant tumors.

Conclusions: Implications for the non-central nervous system tumors on survival of glioblastomas were not found in this research. However, glioblastomas complicated with other malignant tumors still showed worse clinical outcomes.

背景:胶质母细胞瘤(GBM)合并原发性非中枢神经系统(CNS)肿瘤的诊断和治疗仍然是一个挑战,但对这些患者的临床特征和预后知之甚少。本文的数据比较了胶质母细胞瘤合并或不合并原发性非中枢神经系统肿瘤患者的临床和病理特征,试图进一步探讨这一复杂的情况。方法:对2019年1月至2022年2月北京天坛医院诊断为异橼酸脱氢酶(IDH)野生型胶质母细胞瘤合并非中枢神经系统肿瘤的45例患者的临床和病理资料进行统计分析。采用单因素COX比例风险回归模型确定影响总生存的危险因素。结果:45例idh -野生型GBM合并非中枢神经系统肿瘤患者与112例仅诊断为idh -野生型GBM患者的总生存期(OS)无显著差异。然而,良性肿瘤患者的OS与恶性肿瘤患者的OS有显著差异。结论:本研究未发现非中枢神经系统肿瘤对胶质母细胞瘤存活的影响。然而,胶质母细胞瘤合并其他恶性肿瘤仍表现出较差的临床预后。
{"title":"Clinical characteristics and survival of glioblastoma complicated with non-central nervous system tumors.","authors":"Chen Wang,&nbsp;Di Wang,&nbsp;Changqing Pan,&nbsp;Jiazheng Zhang,&nbsp;Cheng Cheng,&nbsp;You Zhai,&nbsp;Mingchen Yu,&nbsp;Zhiliang Wang,&nbsp;Guanzhang Li,&nbsp;Wei Zhang","doi":"10.1186/s41016-022-00312-1","DOIUrl":"https://doi.org/10.1186/s41016-022-00312-1","url":null,"abstract":"<p><strong>Background: </strong>Diagnosis and treatment of patients with glioblastoma (GBM) who are also diagnosed with primary non-central nervous system (CNS) tumors remain a challenge, yet little is known about the clinical characteristics and prognosis of these patients. The data presented here compared the clinical and pathological features between glioblastoma patients with or without primary non-CNS tumors, trying to further explore this complex situation.</p><p><strong>Methods: </strong>Statistical analysis was based on the clinical and pathological data of 45 patients who were diagnosed with isocitrate dehydrogenase (IDH) wild-type glioblastoma accompanied by non-CNS tumors between January 2019 and February 2022 in Beijing Tiantan Hospital. Univariate COX proportional hazard regression model was used to determine risk factors for overall survival.</p><p><strong>Results: </strong>It turned out to be no significant difference in the overall survival (OS) of the 45 patients with IDH-wild-type GBM plus non-CNS tumors, compared with the 112 patients who were only diagnosed with IDH-wild-type GBM. However, there was a significant difference in OS of GBM patients with benign tumors compared to those with malignant tumors.</p><p><strong>Conclusions: </strong>Implications for the non-central nervous system tumors on survival of glioblastomas were not found in this research. However, glioblastomas complicated with other malignant tumors still showed worse clinical outcomes.</p>","PeriodicalId":36700,"journal":{"name":"Chinese Neurosurgical Journal","volume":"8 1","pages":"43"},"PeriodicalIF":0.0,"publicationDate":"2022-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793540/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10449913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors for early seizure after revascularization in patients with moyamoya disease. 烟雾病患者血运重建术后早期发作的危险因素。
Q2 Medicine Pub Date : 2022-12-27 DOI: 10.1186/s41016-022-00305-0
Hongchuan Niu, Cunxin Tan, Kehan Jin, Ran Duan, Guangchao Shi, Rong Wang

Background: To investigate the risk factors for early seizure after revascularization in patients with moyamoya disease (MMD).

Methods: A total of 298 patients with MMD diagnosed in our hospital from 2015 to 2018 were analyzed retrospectively. We summarized the characteristics of seizure after revascularization in patients with MMD and analyzed the predictors of early postoperative seizure.

Results: We identified 15 patients with MMD who developed seizures within 1 week after revascularization. According to logistic regression analysis, age (OR: 1.04, 95% CI 0.998-1.086; P = 0.060) and infarct side (OR: 1.92, 95% CI 0.856-4.290; P = 0.113) were not significantly associated with incident early seizure. Postoperative infarction (OR: 12.89, 95% CI 4.198-39.525; P = 0.000) and preoperative cerebral infarction (OR: 4.08, 95% CI 1.267-13.119; P = 0.018) were confirmed as risk factors for early seizure.

Conclusions: We believe that a history of preoperative infarction and new infarction are independent risk factors of early seizure in patients with MMD after revascularization.

背景:探讨烟雾病(MMD)患者血运重建后早期癫痫发作的危险因素。方法:回顾性分析2015 - 2018年我院确诊的烟雾病患者298例。我们总结了烟雾病患者血运重建后癫痫发作的特点,并分析了术后早期癫痫发作的预测因素。结果:我们确定了15例烟雾病患者,他们在血运重建术后一周内发生癫痫发作。根据logistic回归分析,年龄(OR: 1.04, 95% CI 0.998-1.086;P = 0.060)和梗死侧(OR: 1.92, 95% CI 0.856-4.290;P = 0.113)与早期癫痫发作事件无显著相关。术后梗死(OR: 12.89, 95% CI 4.198-39.525;P = 0.000)和术前脑梗死(OR: 4.08, 95% CI 1.267-13.119;P = 0.018)为早期癫痫发作的危险因素。结论:我们认为术前梗死史和新发梗死是烟雾病患者血运重建术后早期癫痫发作的独立危险因素。
{"title":"Risk factors for early seizure after revascularization in patients with moyamoya disease.","authors":"Hongchuan Niu,&nbsp;Cunxin Tan,&nbsp;Kehan Jin,&nbsp;Ran Duan,&nbsp;Guangchao Shi,&nbsp;Rong Wang","doi":"10.1186/s41016-022-00305-0","DOIUrl":"https://doi.org/10.1186/s41016-022-00305-0","url":null,"abstract":"<p><strong>Background: </strong>To investigate the risk factors for early seizure after revascularization in patients with moyamoya disease (MMD).</p><p><strong>Methods: </strong>A total of 298 patients with MMD diagnosed in our hospital from 2015 to 2018 were analyzed retrospectively. We summarized the characteristics of seizure after revascularization in patients with MMD and analyzed the predictors of early postoperative seizure.</p><p><strong>Results: </strong>We identified 15 patients with MMD who developed seizures within 1 week after revascularization. According to logistic regression analysis, age (OR: 1.04, 95% CI 0.998-1.086; P = 0.060) and infarct side (OR: 1.92, 95% CI 0.856-4.290; P = 0.113) were not significantly associated with incident early seizure. Postoperative infarction (OR: 12.89, 95% CI 4.198-39.525; P = 0.000) and preoperative cerebral infarction (OR: 4.08, 95% CI 1.267-13.119; P = 0.018) were confirmed as risk factors for early seizure.</p><p><strong>Conclusions: </strong>We believe that a history of preoperative infarction and new infarction are independent risk factors of early seizure in patients with MMD after revascularization.</p>","PeriodicalId":36700,"journal":{"name":"Chinese Neurosurgical Journal","volume":"8 1","pages":"44"},"PeriodicalIF":0.0,"publicationDate":"2022-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793645/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10449915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microsurgery for vestibular schwannoma: analysis of short-term clinical outcome. 前庭神经鞘瘤的显微外科治疗:近期临床结果分析。
Q2 Medicine Pub Date : 2022-12-21 DOI: 10.1186/s41016-022-00306-z
Xu Wang, Mingchu Li, Xinru Xiao, Ge Chen, Jie Tang, Qingtang Lin, Hongchuan Guo, Gang Song, Xiaolong Wu, Yuhai Bao, Jiantao Liang

Background: Total removal of the vestibular schwannoma when preserving the function of the facial nerve is difficult. The objective of the current study was to investigate the short-term clinical outcome of vestibular schwannoma removal via retro-sigmoid approach.

Methods: One-hundred consecutive patients diagnosed with vestibular schwannoma were surgically treated between December 2018 and August 2019 in Xuanwu Hospital, Capital Medical University. The clinical classification, surgical position, gross total removal rate, the anatomical and functional preservation rates of facial nerve, and the postoperative complications were retrospectively analyzed.

Results: All 100 patients including 34 males and 66 females were operated on via retro-sigmoid approach. According to Koos vestibular schwannoma grading system, 18 cases were grade 2, 34 cases were grade 3, and 48 cases were grade 4. According to Hannover vestibular schwannoma grading system, 5 cases were T2, 6 cases were T3a, 8 cases were T3b, 30 cases were T4a, and 51 cases were T4b. Seventy-three surgeries were performed under lateral position, and 27 cases were operated under semi-sitting position. The gross total removal rate was 90.0%; the anatomic reservation rate of the facial nerve was 96.0%. According to the House-Brackman system, the facial nerve function was grades 1-2 in 78.0% cases, grade 3 in 7.0% cases, and grades 4-5 in 15% cases. For patients with effective hearing before operation, the hearing reservation rate was 19.0%. Two patients (2.0%) developed intracranial hematoma after operation.

Conclusion: Most vestibular schwannoma could be completely removed with good postoperative facial nerve function. If total removal of tumor is difficult, we should give priority to the functional preservation of the nerve function.

背景:在保留面神经功能的情况下,完全切除前庭神经鞘瘤是困难的。本研究的目的是探讨经乙状结肠后入路前庭神经鞘瘤切除术的短期临床结果。方法:2018年12月至2019年8月,在首都医科大学宣武医院连续手术治疗100例前庭神经鞘瘤患者。回顾性分析面神经的临床分型、手术体位、大体全切除率、解剖功能保存率及术后并发症。结果:100例患者均行乙状结肠后入路手术,其中男34例,女66例。根据Koos前庭神经鞘瘤分级,2级18例,3级34例,4级48例。按照汉诺威前庭神经鞘瘤分级系统,T2 5例,T3a 6例,T3b 8例,T4a 30例,T4b 51例。侧卧位手术73例,半坐位手术27例。总去除率为90.0%;面神经解剖保留率为96.0%。根据House-Brackman系统,面部神经功能1-2级占78.0%,3级占7.0%,4-5级占15%。术前听力有效的患者,听力保留率为19.0%。术后颅内血肿2例(2.0%)。结论:大部分前庭神经鞘瘤可完全切除,术后面神经功能良好。如果肿瘤难以完全切除,应优先考虑神经功能的功能性保留。
{"title":"Microsurgery for vestibular schwannoma: analysis of short-term clinical outcome.","authors":"Xu Wang,&nbsp;Mingchu Li,&nbsp;Xinru Xiao,&nbsp;Ge Chen,&nbsp;Jie Tang,&nbsp;Qingtang Lin,&nbsp;Hongchuan Guo,&nbsp;Gang Song,&nbsp;Xiaolong Wu,&nbsp;Yuhai Bao,&nbsp;Jiantao Liang","doi":"10.1186/s41016-022-00306-z","DOIUrl":"https://doi.org/10.1186/s41016-022-00306-z","url":null,"abstract":"<p><strong>Background: </strong>Total removal of the vestibular schwannoma when preserving the function of the facial nerve is difficult. The objective of the current study was to investigate the short-term clinical outcome of vestibular schwannoma removal via retro-sigmoid approach.</p><p><strong>Methods: </strong>One-hundred consecutive patients diagnosed with vestibular schwannoma were surgically treated between December 2018 and August 2019 in Xuanwu Hospital, Capital Medical University. The clinical classification, surgical position, gross total removal rate, the anatomical and functional preservation rates of facial nerve, and the postoperative complications were retrospectively analyzed.</p><p><strong>Results: </strong>All 100 patients including 34 males and 66 females were operated on via retro-sigmoid approach. According to Koos vestibular schwannoma grading system, 18 cases were grade 2, 34 cases were grade 3, and 48 cases were grade 4. According to Hannover vestibular schwannoma grading system, 5 cases were T2, 6 cases were T3a, 8 cases were T3b, 30 cases were T4a, and 51 cases were T4b. Seventy-three surgeries were performed under lateral position, and 27 cases were operated under semi-sitting position. The gross total removal rate was 90.0%; the anatomic reservation rate of the facial nerve was 96.0%. According to the House-Brackman system, the facial nerve function was grades 1-2 in 78.0% cases, grade 3 in 7.0% cases, and grades 4-5 in 15% cases. For patients with effective hearing before operation, the hearing reservation rate was 19.0%. Two patients (2.0%) developed intracranial hematoma after operation.</p><p><strong>Conclusion: </strong>Most vestibular schwannoma could be completely removed with good postoperative facial nerve function. If total removal of tumor is difficult, we should give priority to the functional preservation of the nerve function.</p>","PeriodicalId":36700,"journal":{"name":"Chinese Neurosurgical Journal","volume":"8 1","pages":"42"},"PeriodicalIF":0.0,"publicationDate":"2022-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768882/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10768174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A falcotentorial dural arteriovenous fistula presented as carotid cavernous fistula clinically treated by transarterial embolization: case report. 经动脉栓塞治疗镰状脑膜动静脉瘘临床表现为颈动脉海绵瘘1例。
Q2 Medicine Pub Date : 2022-12-14 DOI: 10.1186/s41016-022-00309-w
Yuan Shi, Peixi Liu, Yingtao Liu, Kai Quan, Yanlong Tian, Wei Zhu

Background: Dural arteriovenous fistulas (DAVF) represent almost 10-15% of intracranial malformations that cause intracranial hemorrhage and focal neurological deficits. Seldom tentorial DAVF cases present with ocular manifestations initially, which occur frequently in carotid-cavernous fistula (CCF) and cavernous sinus DAVF (CS DAVF).

Case presentation: We report an unusual falcotentorial DAVF case draining via the superior and inferior ophthalmic veins that caused left-side increased intraocular pressure. The patient's chief complaint was swelling on the left side, pain and conjunctival congestion. He received endovascular embolization via a transarterial approach, and postoperative angiography demonstrated that the falcotentorial DAVF was occluded completely.

Conclusion: Except for CCF and CS DAVF, some specific subtypes of DAVF should be considered if the patient initially presents with ocular symptoms. Differential diagnosis and definitive treatment are mandatory to avoid a delayed diagnosis and irreversible symptoms.

背景:硬脑膜动静脉瘘(DAVF)占颅内畸形的近10-15%,导致颅内出血和局灶性神经功能缺损。幕部DAVF很少以眼部为首发表现,多见于颈海绵状瘘(CCF)和海绵窦DAVF (CS DAVF)。病例介绍:我们报告一个不寻常的镰状眼静脉瘘病例,通过眼上和眼下静脉引流,导致左侧眼压升高。病人的主诉是左侧肿胀、疼痛和结膜充血。经动脉入路行血管内栓塞术,术后血管造影显示镰幕DAVF完全闭塞。结论:除CCF和CS型DAVF外,如果患者最初出现眼部症状,应考虑一些特定亚型的DAVF。鉴别诊断和明确治疗是必要的,以避免延误诊断和不可逆转的症状。
{"title":"A falcotentorial dural arteriovenous fistula presented as carotid cavernous fistula clinically treated by transarterial embolization: case report.","authors":"Yuan Shi,&nbsp;Peixi Liu,&nbsp;Yingtao Liu,&nbsp;Kai Quan,&nbsp;Yanlong Tian,&nbsp;Wei Zhu","doi":"10.1186/s41016-022-00309-w","DOIUrl":"https://doi.org/10.1186/s41016-022-00309-w","url":null,"abstract":"<p><strong>Background: </strong>Dural arteriovenous fistulas (DAVF) represent almost 10-15% of intracranial malformations that cause intracranial hemorrhage and focal neurological deficits. Seldom tentorial DAVF cases present with ocular manifestations initially, which occur frequently in carotid-cavernous fistula (CCF) and cavernous sinus DAVF (CS DAVF).</p><p><strong>Case presentation: </strong>We report an unusual falcotentorial DAVF case draining via the superior and inferior ophthalmic veins that caused left-side increased intraocular pressure. The patient's chief complaint was swelling on the left side, pain and conjunctival congestion. He received endovascular embolization via a transarterial approach, and postoperative angiography demonstrated that the falcotentorial DAVF was occluded completely.</p><p><strong>Conclusion: </strong>Except for CCF and CS DAVF, some specific subtypes of DAVF should be considered if the patient initially presents with ocular symptoms. Differential diagnosis and definitive treatment are mandatory to avoid a delayed diagnosis and irreversible symptoms.</p>","PeriodicalId":36700,"journal":{"name":"Chinese Neurosurgical Journal","volume":"8 1","pages":"41"},"PeriodicalIF":0.0,"publicationDate":"2022-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749196/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10353922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The risk factors of hemorrhage in stereotactic needle biopsy for brain lesions in a large cohort: 10 years of experience in a single center. 大队列脑病变立体定向穿刺活检出血的危险因素:单中心10年经验
Q2 Medicine Pub Date : 2022-12-09 DOI: 10.1186/s41016-022-00307-y
Hailong Li, Chunling Zheng, Wei Rao, Junzhao Sun, Xin Yu, Jianning Zhang

Background: This study aimed to identify the risk factors for hemorrhage from a large cohort who underwent stereotactic needle biopsy for brain lesions at a single center over a 10-year period.

Methods: We performed a retrospective chart review of consecutive patients who underwent stereotactic biopsy at our institute between January 2010 and December 2019. Demographic characteristics and clinical variables were collected and analyzed to identify risk factors for postbiopsy hemorrhage using the chi-square test and univariable and multivariable logistic regression analyses.

Results: A total of 3196 patients were included in this study; of these, a histological diagnosis was eventually made for 2938 (91.93%) patients. Hemorrhage occurred in 149 (4.66%) patients, and symptomatic hemorrhage occurred in 46 (1.44%) patients. In multivariable logistic regression analyses, the presence of deep-seated lesions (OR 1.272, p = 0.035), concomitant edema and enhancement on MR imaging scans (OR 1.827, p = 0.002), intraoperative hypertension without a past history (OR 1.012, p = 0.024), and the presence of high-grade glioma (OR 0.306, p = 0.003) were identified as independent predictors of hemorrhage after biopsy.

Conclusion: Stereotactic needle biopsy is a safe and effective way to obtain tissue from brain lesions for histological diagnosis. The presence of deep-seated lesions, concomitant edema, and enhancement on MR imaging scans and the presence of high-grade glioma are independent predictors of hemorrhage after stereotactic biopsy.

背景:本研究旨在从一个大队列中确定出血的危险因素,该队列在一个中心进行了10年的脑病变立体定向针活检。方法:我们对2010年1月至2019年12月期间在我们研究所接受立体定向活检的连续患者进行回顾性图表回顾。采用卡方检验、单变量和多变量logistic回归分析收集和分析人口统计学特征和临床变量,以确定活检后出血的危险因素。结果:本研究共纳入3196例患者;其中,2938例(91.93%)患者最终进行了组织学诊断。出血149例(4.66%),有症状出血46例(1.44%)。在多变量logistic回归分析中,深部病变的存在(OR 1.272, p = 0.035)、伴发水肿和磁共振成像增强(OR 1.827, p = 0.002)、术中无既往史的高血压(OR 1.012, p = 0.024)和高级别胶质瘤的存在(OR 0.306, p = 0.003)被确定为活检后出血的独立预测因素。结论:立体定向针活检是一种安全、有效的脑组织活检方法。存在深部病变、伴随水肿、磁共振成像扫描增强和高级别胶质瘤的存在是立体定向活检后出血的独立预测因素。
{"title":"The risk factors of hemorrhage in stereotactic needle biopsy for brain lesions in a large cohort: 10 years of experience in a single center.","authors":"Hailong Li,&nbsp;Chunling Zheng,&nbsp;Wei Rao,&nbsp;Junzhao Sun,&nbsp;Xin Yu,&nbsp;Jianning Zhang","doi":"10.1186/s41016-022-00307-y","DOIUrl":"https://doi.org/10.1186/s41016-022-00307-y","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to identify the risk factors for hemorrhage from a large cohort who underwent stereotactic needle biopsy for brain lesions at a single center over a 10-year period.</p><p><strong>Methods: </strong>We performed a retrospective chart review of consecutive patients who underwent stereotactic biopsy at our institute between January 2010 and December 2019. Demographic characteristics and clinical variables were collected and analyzed to identify risk factors for postbiopsy hemorrhage using the chi-square test and univariable and multivariable logistic regression analyses.</p><p><strong>Results: </strong>A total of 3196 patients were included in this study; of these, a histological diagnosis was eventually made for 2938 (91.93%) patients. Hemorrhage occurred in 149 (4.66%) patients, and symptomatic hemorrhage occurred in 46 (1.44%) patients. In multivariable logistic regression analyses, the presence of deep-seated lesions (OR 1.272, p = 0.035), concomitant edema and enhancement on MR imaging scans (OR 1.827, p = 0.002), intraoperative hypertension without a past history (OR 1.012, p = 0.024), and the presence of high-grade glioma (OR 0.306, p = 0.003) were identified as independent predictors of hemorrhage after biopsy.</p><p><strong>Conclusion: </strong>Stereotactic needle biopsy is a safe and effective way to obtain tissue from brain lesions for histological diagnosis. The presence of deep-seated lesions, concomitant edema, and enhancement on MR imaging scans and the presence of high-grade glioma are independent predictors of hemorrhage after stereotactic biopsy.</p>","PeriodicalId":36700,"journal":{"name":"Chinese Neurosurgical Journal","volume":"8 1","pages":"40"},"PeriodicalIF":0.0,"publicationDate":"2022-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732999/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10321689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Thrombospondin-2 promotes the proliferation and migration of glioma cells and contributes to the progression of glioma. 血小板反应蛋白-2促进胶质瘤细胞的增殖和迁移,促进胶质瘤的进展。
Q2 Medicine Pub Date : 2022-12-07 DOI: 10.1186/s41016-022-00308-x
Tian-Lan Huang, Yi-Wen Mei, Yang Li, Xin Chen, Si-Xun Yu, Yong-Qin Kuang, Hai-Feng Shu

Background: Gliomas, especially high-grade gliomas, are highly malignant with a poor prognosis. Although existing treatments have improved the survival rate of patients with glioma, the recurrence and mortality rates are still not ideal. The molecular mechanisms involved in the occurrence and development of glioma are still poorly understood. We previously reported that thrombospondin-2 (TSP2) expression was increased in tumor specimens from rat models, promoting excitatory synapse formation. However, little is known about the effect of TSP2 on the biological characteristics of glioma.

Methods: Glioma and cerebral cortex tissues were collected from 33 patients, and the expression of TSP2 in them was analyzed. Next, the proliferation and migration of TSP2 on glioma cells were analyzed in vitro. At last, a glioma transplantation model was constructed to explore the growth of TSP2 on glioma in vivo.

Results: The expression of TSP2 in surgical glioma specimens was increased compared to that in the normal cortex. Interestingly, the TSP2 protein level was higher in high-grade glioma (HGG, World Health Organization (WHO) grades 3-4) than in low-grade glioma (LGG, WHO grades 1-2) tissues. Exogenous addition of the TSP2 protein at an appropriate concentration promoted the migration of glioma cells but did not significantly affect their proliferation. Surprisingly, overexpression of TSP2 promoted both the migration and proliferation of cultured glioma cells. Moreover, in vivo experimental data implied that overexpression of TSP2 in C6 cells promoted the malignant growth of gliomas, while knockout of TSP2 slowed glioma growth.

Conclusions: TSP2 promotes the migration and proliferation of glioma cells, which may provide new ideas for blocking glioma progression.

背景:胶质瘤,尤其是高级别胶质瘤,是高度恶性且预后差的疾病。虽然现有的治疗方法提高了胶质瘤患者的生存率,但其复发率和死亡率仍然不理想。胶质瘤发生发展的分子机制尚不清楚。我们之前报道了血栓反应蛋白-2 (TSP2)在大鼠模型肿瘤标本中的表达增加,促进兴奋性突触的形成。然而,关于TSP2对胶质瘤生物学特性的影响知之甚少。方法:收集33例胶质瘤和大脑皮层组织,分析其TSP2的表达情况。接下来,我们在体外分析了TSP2在胶质瘤细胞上的增殖和迁移。最后构建胶质瘤移植模型,探讨TSP2在胶质瘤体内的生长情况。结果:TSP2在脑胶质瘤组织中的表达明显高于正常脑组织。有趣的是,TSP2蛋白水平在高级别胶质瘤(HGG,世界卫生组织分级3-4)中高于低级别胶质瘤(LGG, WHO分级1-2)组织。外源添加适当浓度的TSP2蛋白可促进胶质瘤细胞的迁移,但对胶质瘤细胞的增殖无显著影响。令人惊讶的是,TSP2的过表达促进了培养的胶质瘤细胞的迁移和增殖。此外,体内实验数据表明,C6细胞中过表达TSP2可促进胶质瘤的恶性生长,而敲除TSP2可减缓胶质瘤的生长。结论:TSP2促进胶质瘤细胞的迁移和增殖,可能为阻断胶质瘤的进展提供新的思路。
{"title":"Thrombospondin-2 promotes the proliferation and migration of glioma cells and contributes to the progression of glioma.","authors":"Tian-Lan Huang,&nbsp;Yi-Wen Mei,&nbsp;Yang Li,&nbsp;Xin Chen,&nbsp;Si-Xun Yu,&nbsp;Yong-Qin Kuang,&nbsp;Hai-Feng Shu","doi":"10.1186/s41016-022-00308-x","DOIUrl":"https://doi.org/10.1186/s41016-022-00308-x","url":null,"abstract":"<p><strong>Background: </strong>Gliomas, especially high-grade gliomas, are highly malignant with a poor prognosis. Although existing treatments have improved the survival rate of patients with glioma, the recurrence and mortality rates are still not ideal. The molecular mechanisms involved in the occurrence and development of glioma are still poorly understood. We previously reported that thrombospondin-2 (TSP2) expression was increased in tumor specimens from rat models, promoting excitatory synapse formation. However, little is known about the effect of TSP2 on the biological characteristics of glioma.</p><p><strong>Methods: </strong>Glioma and cerebral cortex tissues were collected from 33 patients, and the expression of TSP2 in them was analyzed. Next, the proliferation and migration of TSP2 on glioma cells were analyzed in vitro. At last, a glioma transplantation model was constructed to explore the growth of TSP2 on glioma in vivo.</p><p><strong>Results: </strong>The expression of TSP2 in surgical glioma specimens was increased compared to that in the normal cortex. Interestingly, the TSP2 protein level was higher in high-grade glioma (HGG, World Health Organization (WHO) grades 3-4) than in low-grade glioma (LGG, WHO grades 1-2) tissues. Exogenous addition of the TSP2 protein at an appropriate concentration promoted the migration of glioma cells but did not significantly affect their proliferation. Surprisingly, overexpression of TSP2 promoted both the migration and proliferation of cultured glioma cells. Moreover, in vivo experimental data implied that overexpression of TSP2 in C6 cells promoted the malignant growth of gliomas, while knockout of TSP2 slowed glioma growth.</p><p><strong>Conclusions: </strong>TSP2 promotes the migration and proliferation of glioma cells, which may provide new ideas for blocking glioma progression.</p>","PeriodicalId":36700,"journal":{"name":"Chinese Neurosurgical Journal","volume":"8 1","pages":"39"},"PeriodicalIF":0.0,"publicationDate":"2022-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728004/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10695641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Plaque characteristics after endovascular treatment in patients with intracranial atherosclerotic disease. 颅内动脉粥样硬化性疾病患者血管内治疗后斑块特征。
Q2 Medicine Pub Date : 2022-12-02 DOI: 10.1186/s41016-022-00302-3
Shun Zhang, Junjie Wang, Jun Lu, Peng Qi, Shen Hu, Ximeng Yang, Kunpeng Chen, Daming Wang

Background: Endovascular treatment (EVT) is an alternative option for symptomatic intracranial atherosclerotic disease (ICAD). However, the effect of EVT treatment on ICAD plaques is still unclear. This study describes the ICAD plaque characteristics after EVT treatment and analyzes the effect of different EVT treatments on plaque characteristics.

Method: From 2017 January to 2022 January, ICAD patients who underwent endovascular treatment and had follow-up high-resolution magnetic resonance image (HRMRI) were enrolled in the study. Multiple plaque characteristics, including plaque enhancement, plaque burden, were measured based on preoperative, and follow-up HRMRI. Plaque characteristics and postoperative plaque changes were analyzed between different treatment groups.

Result: Finally, 50 intracranial atherosclerotic plaques in 45 patients were included. Including 28 male patients and 17 female, media age 63.0 years old. Among 50 plaques, 41 received percutaneous angioplasty (including 22 plain balloons and 19 drug-coated balloons (DCB)) and the other 9 underwent stenting. Stenosis rate, plaque burden and eccentricity index at the lesion site were significantly decreased after EVT compared with preoperative periods (p <0.001). And only the DCB group showed a significant reduction in plaque enhancement at follow-up (p < 0.001). No significant preoperative and postoperative changes in other plaque characteristics were found.

Conclusion: EVT treatment could compromise the characteristics of intracranial periarterial atherosclerotic plaques, and DCB treatment may result in a reduction in plaque enhancement after treatment.

背景:血管内治疗(EVT)是治疗症状性颅内动脉粥样硬化疾病(ICAD)的另一种选择。然而,EVT治疗对ICAD斑块的影响尚不清楚。本研究描述了EVT治疗后的ICAD斑块特征,并分析了不同EVT治疗对斑块特征的影响。方法:选取2017年1月至2022年1月接受血管内治疗并随访高分辨率磁共振成像(HRMRI)的ICAD患者为研究对象。在术前和随访HRMRI的基础上测量多种斑块特征,包括斑块增强、斑块负荷。分析不同治疗组斑块特征及术后斑块变化。结果:最终纳入45例患者50个颅内动脉粥样硬化斑块。其中男28例,女17例,中位年龄63.0岁。在50个斑块中,41个接受了经皮血管成形术(包括22个普通球囊和19个药物包被球囊(DCB)),另外9个接受了支架植入术。EVT后病变部位狭窄率、斑块负荷、偏心率指数较术前明显降低(p)。结论:EVT治疗可损害颅内动脉粥样硬化斑块特征,DCB治疗可降低治疗后斑块强化。
{"title":"Plaque characteristics after endovascular treatment in patients with intracranial atherosclerotic disease.","authors":"Shun Zhang,&nbsp;Junjie Wang,&nbsp;Jun Lu,&nbsp;Peng Qi,&nbsp;Shen Hu,&nbsp;Ximeng Yang,&nbsp;Kunpeng Chen,&nbsp;Daming Wang","doi":"10.1186/s41016-022-00302-3","DOIUrl":"https://doi.org/10.1186/s41016-022-00302-3","url":null,"abstract":"<p><strong>Background: </strong>Endovascular treatment (EVT) is an alternative option for symptomatic intracranial atherosclerotic disease (ICAD). However, the effect of EVT treatment on ICAD plaques is still unclear. This study describes the ICAD plaque characteristics after EVT treatment and analyzes the effect of different EVT treatments on plaque characteristics.</p><p><strong>Method: </strong>From 2017 January to 2022 January, ICAD patients who underwent endovascular treatment and had follow-up high-resolution magnetic resonance image (HRMRI) were enrolled in the study. Multiple plaque characteristics, including plaque enhancement, plaque burden, were measured based on preoperative, and follow-up HRMRI. Plaque characteristics and postoperative plaque changes were analyzed between different treatment groups.</p><p><strong>Result: </strong>Finally, 50 intracranial atherosclerotic plaques in 45 patients were included. Including 28 male patients and 17 female, media age 63.0 years old. Among 50 plaques, 41 received percutaneous angioplasty (including 22 plain balloons and 19 drug-coated balloons (DCB)) and the other 9 underwent stenting. Stenosis rate, plaque burden and eccentricity index at the lesion site were significantly decreased after EVT compared with preoperative periods (p <0.001). And only the DCB group showed a significant reduction in plaque enhancement at follow-up (p < 0.001). No significant preoperative and postoperative changes in other plaque characteristics were found.</p><p><strong>Conclusion: </strong>EVT treatment could compromise the characteristics of intracranial periarterial atherosclerotic plaques, and DCB treatment may result in a reduction in plaque enhancement after treatment.</p>","PeriodicalId":36700,"journal":{"name":"Chinese Neurosurgical Journal","volume":"8 1","pages":"37"},"PeriodicalIF":0.0,"publicationDate":"2022-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716672/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10328982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intradural extramedullary cervical metastasis from Merkel cell carcinoma: a case report and literature review. 默克尔细胞癌硬膜内髓外宫颈转移一例报告并文献复习。
Q2 Medicine Pub Date : 2022-12-02 DOI: 10.1186/s41016-022-00310-3
Giovanni Pennisi, Andrea Talacchi, Marcello Nunzio Tirendi, Marco Giordano, Alessandro Olivi

Background: Merkel cell carcinoma (MCC) is a rare aggressive primary skin carcinoma with an incidence of 44 cases per 100,000. The natural course of MCC often results in rapid growth and early metastasis. On the other hand, the spinal cord is rarely affected and frequently features the end stage of the disease. The aim of this paper was to clarify the management of patients with spine metastasis from a skin lesion and showed a case-based update.

Case presentation: A 73-year-old female was admitted to the Neurosurgical Department in December 2021 for a sudden right hemiparesis with bladder dysfunction and a history of cutaneous Merkel cell carcinoma. A magnetic resonance imaging (MRI) of the central nervous system (CNS) showed an intradural-extramedullary right-sided C6-C7 tumor with mass effect and edema of the cervical cord. The patient underwent a C6-C7 laminectomy with microsurgical total resection of the intradural extramedullary lesion. The neuropathological examination identified a metastasis from Merkel cell carcinoma. Nowadays, evidence for spinal metastasis from malignities skin cancer is generally lacking, probably because they are extremely rare. The exact time of life expectancy is controversial, and some clinicians use a cutoff of 3 months to determine whether surgical intervention should be offered, while others advocate at least 6 months of life expectancy.

Conclusions: To the best of our knowledge, we showed the first case of solitary intradural extramedullary cervical spine metastasis from MCC. We recommend to consider metastasis of MCC in the differential diagnosis of spinal metastasis.

背景:默克尔细胞癌(MCC)是一种罕见的侵袭性原发性皮肤癌,发病率为每10万人44例。MCC的自然过程通常导致快速生长和早期转移。另一方面,脊髓很少受到影响,并且经常以疾病的终末期为特征。本文的目的是阐明皮肤病变的脊柱转移患者的管理,并显示了基于病例的更新。病例介绍:一名73岁女性于2021年12月因突发性右半瘫合并膀胱功能障碍和皮肤默克尔细胞癌病史入院神经外科。中枢神经系统(CNS)磁共振成像(MRI)显示硬膜内-髓外右侧C6-C7肿瘤伴团块效应和颈髓水肿。患者行C6-C7椎板切除术,显微手术切除硬膜内髓外病变。神经病理学检查发现默克尔细胞癌转移。目前,恶性皮肤癌脊柱转移的证据普遍缺乏,可能是因为它们极其罕见。预期寿命的确切时间是有争议的,一些临床医生使用3个月的截止时间来确定是否应该进行手术干预,而另一些人则主张至少6个月的预期寿命。结论:据我们所知,我们报道了首例MCC孤立性硬膜内髓外颈椎转移病例。我们建议在脊柱转移的鉴别诊断中考虑MCC的转移。
{"title":"Intradural extramedullary cervical metastasis from Merkel cell carcinoma: a case report and literature review.","authors":"Giovanni Pennisi,&nbsp;Andrea Talacchi,&nbsp;Marcello Nunzio Tirendi,&nbsp;Marco Giordano,&nbsp;Alessandro Olivi","doi":"10.1186/s41016-022-00310-3","DOIUrl":"https://doi.org/10.1186/s41016-022-00310-3","url":null,"abstract":"<p><strong>Background: </strong>Merkel cell carcinoma (MCC) is a rare aggressive primary skin carcinoma with an incidence of 44 cases per 100,000. The natural course of MCC often results in rapid growth and early metastasis. On the other hand, the spinal cord is rarely affected and frequently features the end stage of the disease. The aim of this paper was to clarify the management of patients with spine metastasis from a skin lesion and showed a case-based update.</p><p><strong>Case presentation: </strong>A 73-year-old female was admitted to the Neurosurgical Department in December 2021 for a sudden right hemiparesis with bladder dysfunction and a history of cutaneous Merkel cell carcinoma. A magnetic resonance imaging (MRI) of the central nervous system (CNS) showed an intradural-extramedullary right-sided C6-C7 tumor with mass effect and edema of the cervical cord. The patient underwent a C6-C7 laminectomy with microsurgical total resection of the intradural extramedullary lesion. The neuropathological examination identified a metastasis from Merkel cell carcinoma. Nowadays, evidence for spinal metastasis from malignities skin cancer is generally lacking, probably because they are extremely rare. The exact time of life expectancy is controversial, and some clinicians use a cutoff of 3 months to determine whether surgical intervention should be offered, while others advocate at least 6 months of life expectancy.</p><p><strong>Conclusions: </strong>To the best of our knowledge, we showed the first case of solitary intradural extramedullary cervical spine metastasis from MCC. We recommend to consider metastasis of MCC in the differential diagnosis of spinal metastasis.</p>","PeriodicalId":36700,"journal":{"name":"Chinese Neurosurgical Journal","volume":"8 1","pages":"38"},"PeriodicalIF":0.0,"publicationDate":"2022-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716679/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10678682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Chinese Neurosurgical Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1